FDA Considers Major Shift in COVID Vaccine Strategy | KQED
Briefly

The agency notes that if a more dangerous COVID variant were to emerge, it might reconsider the vaccine strain at other times of the year on an "as-needed and emergent basis."Some immunologists and vaccine researchers say simplifying the process along the lines of the flu vaccine is appropriate at this point in the pandemic.
Read at KQED
[
add
]
[
|
|
]